We understand that early discovery is a critical stage in your drug development program. The ability to rule out unsuitable drug candidates early in the process is key to the successful development of a new therapeutic. Charles River offers streamlined discovery capabilities to meet the rapid timelines and diverse needs required for the most efficient target validation and drug candidate ranking and selection process.
More than ever, you need a discovery partner you can trust. Working in close collaboration with you, Charles River Discovery Services offers customized screening programs to ensure early and late lead candidate optimization. With multiple facilities and expert staff in North America, Europe, and Asia, we help close the gap between the output of combinatorial chemistry and high-throughput screening and the safety testing required prior to initiation of your clinical studies. Whether you need a single study or intend to outsource your entire discovery program, our capacity and portfolio of services can help move your product from animal to man in a rational, cost-effective, and timely manner.
To supplement your discovery programs, we offer a full range of basic research services, including Disease Models, Surgical Services, and Expression Testing. Once your drug has passed the discovery milestone, we provide a seamless transition to Preclinical Development and Clinical Trials, creating a more efficient program that can save you valuable time and accelerate your drug development, exactly.